Jonathan Wright, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 100 Wynnwood Dr, Franklin, VA 23851 Phone: 757-651-8304 Fax: 660-826-4852 |
Mr. Michael Wayne Jackson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 100 Fairview Dr, Southampton Memorial Hospital, Franklin, VA 23851 Phone: 757-569-6125 |
Brian R. Smith, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 100 Fairview Dr, Franklin, VA 23851 Phone: 757-569-6100 |
Peter William James, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 100 Fairview Dr, Franklin, VA 23851 Phone: 757-569-6277 |
News Archive
Agilent Technologies Inc. (NYSE:A) today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration.
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically-an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
Episodes of dizziness tend to become less frequent over time in patients with Ménière's disease, a condition characterized by vertigo, hearing loss and ringing in the ears, according to a report in the November issue of Archives of Otolaryngology–Head & Neck Surgery.
NanoViricides, Inc. said it has signed a non-disclosure agreement with the Lovelace Respiratory Research Institute. The Company intends to enter into a Master Services Agreement with LRRI for the IND-enabling efficacy studies of both its broad-spectrum injectable and oral FluCide drug candidates.
› Verified 2 days ago